明達
明達醫 Stock: price and insider trades · Taiwan
明達醫: what insiders have been doing
明達醫 has a thin disclosure history in our data (latest filing: 23 July 2021). New filings will appear here as soon as they are published. Source: insider filings from TWSE / TPEx (MOPS). Past trades are no guide to future returns.
Insider Decl.
11
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 5,698 of 26,911 companies
66.3
score / 100
Value56
Quality77
FCF yld-2.5%
Earn yld8.0%
EV/EBITDA9.3x
ROE15%
Gross mgn35%
Net mgn15%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$72
Analyst consensus
Income statement
RevenueNT$949M
Gross profitNT$331.9M35% margin
EBITDANT$197.3M21% margin
Net incomeNT$147M17.0% margin
Valuation
PER (trailing)12.6x
P/Book1.8x
Beta0.71
Balance sheet & cash
Market capNT$1.8B
Total debtNT$11.7M
Free Cash Flow-NT$46.1M
Debt / Equity4%
Profitability & ownership
ROE14.9%
ROA8.1%
% insiders46.9%
% institutions0.0%
Last declaration on 23 July 2021
Declarations11 total
- 20,000 sharesShareTPExTWMOPS:6527:110/07/23:黃文煒:1pyrlhw
- 60,000 sharesShareTPExTWMOPS:6527:108/12/13:普訊玖創業投資股份有限公司:0ghi60e
- 60,000 sharesShareTPExTWMOPS:6527:108/12/13:盛弘醫藥股份有限公司:1e4wsji
- 200,000 sharesShareTPExTWMOPS:6527:104/11/10:林清宏:0f94whi
- 130,000 sharesShareTPExTWMOPS:6527:104/04/24:莊仲平之配偶:10yvuvm
- 22,000 sharesShareTPExTWMOPS:6527:104/04/23:普訊陸創業投資股份有限公司:0uuzi67
- 1,000 sharesShareTPExTWMOPS:6527:104/04/23:台達資本股份有限公司:1fp95qn
- 31,000 sharesShareTPExTWMOPS:6527:104/04/23:台達資本股份有限公司:10mj22u
- 87,000 sharesShareTPExTWMOPS:6527:104/04/23:台達資本股份有限公司:1pwy85q
- 87,000 sharesShareTPExTWMOPS:6527:104/04/23:盛弘醫藥股份有限公司:11uz9du
- 127,000 sharesShareTPExTWMOPS:6527:104/04/23:和通創業投資股份有限公司:0nfp8mo
11 of 11 declarations
About 明達醫
Mingda Medical is a company listed on the XTAI market, specializing in the healthcare sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
